Evidence map›Paper›PMID 42418215›Full record

ArticleJournal of applied clinical medical physics2026

AI-surrogate structure and dose correlation for left anterior descending artery in lung stereotactic body radiotherapy.

Grace Chang, Quan Chen, Randa Tao, Libing Zhu, Yi Rong, Nathan Y Yu

Abstract read
In one paragraph

Article in Journal of applied clinical medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Grace ChangDepartment of Radiation Oncology, Mayo Clinic Arizona, Phoenix, Arizona, USA.
Quan ChenDepartment of Radiation Oncology, Mayo Clinic Arizona, Phoenix, Arizona, USA.
Randa TaoDepartment of Radiation Oncology, Mayo Clinic Arizona, Phoenix, Arizona, USA.
Libing ZhuDepartment of Radiation Oncology, Mayo Clinic Arizona, Phoenix, Arizona, USA.
Yi RongDepartment of Radiation Oncology, Mayo Clinic Arizona, Phoenix, Arizona, USA.
Nathan Y YuDepartment of Radiation Oncology, Mayo Clinic Arizona, Phoenix, Arizona, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe left anterior descending (LAD) coronary artery is a critical organ-at-risk in thoracic radiotherapy. In thoracic stereotactic body radiation therapy (SBRT), sharp dose gradients and poor LAD contrast on 4DCT scans introduce uncertainty in LAD dose assessment.

methodsWe evaluated the performance of an AI-generated LAD region structure as a surrogate for manual LAD contours in early-stage NSCLC. We used deep inspiration breath hold (DIBH) scans from 49 patients with manually delineated LADs; planning risk volume contours were expanded by 3 mm. Then, 96 lung SBRT dose maps were registered by matching the left anterior portion of the heart contours. Dice similarity coefficient (DSC), inclusion ratios (IR), dose-volume histogram (DVH) metrics, linear regression, and linear mixed models were used to compare the structures. The correlation of the AI LAD region and LAD dose to mean heart dose (MHD) was assessed.

resultsThe AI LAD region showed strong correlation with manual LAD contours for maximum dose (D1%, R DISCUSSION: To investigate dose volume effects to the LAD during radiotherapy for stage I NSCLC, a robust segmentation paradigm must be established. It must be easily implementable on typical imaging acquired during treatment, with an emphasis on clinical translatability. Our model has shown that the AI LAD region has a strong correlation with LAD dose under typical lung SBRT doses and supports its use for further investigation into LAD dose volume constraints during lung SBRT.

conclusionAI LAD region provides a clinically feasible and scalable alternative to manual LAD contouring for dose estimation in lung SBRT. Its strong correlation with key dose metrics validates its use in large-scale retrospective and prospective studies.

Indexed as

Artificial IntelligenceCarcinoma, Non-Small-Cell LungCoronary VesselsImage Processing, Computer-AssistedLung NeoplasmsOrgans at RiskRadiosurgeryRadiotherapy Planning, Computer-AssistedFour-Dimensional Computed TomographyHumansRadiotherapy DosageRadiotherapy, Intensity-ModulatedAI segmentationleft descending arteryLung SBRTmean heart dose

Identifiers

PMID42418215
PMCPMC13344228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.